mRNA |
Oxaliplatin |
CTRPv2 |
pan-cancer |
AAC |
0.15 |
5e-06 |
mRNA |
doxorubicin:navitoclax (2:1 mol/mol) |
CTRPv2 |
pan-cancer |
AAC |
0.15 |
6e-06 |
mRNA |
BIX-01294 |
CTRPv2 |
pan-cancer |
AAC |
0.15 |
8e-06 |
mRNA |
austocystin d |
CTRPv2 |
pan-cancer |
AAC |
0.16 |
9e-06 |
mRNA |
ABT-263 |
CTRPv2 |
pan-cancer |
AAC |
0.15 |
1e-05 |
mRNA |
BRD-A02303741:navitoclax (2:1 mol/mol) |
CTRPv2 |
pan-cancer |
AAC |
0.15 |
2e-05 |
mRNA |
alisertib:navitoclax (2:1 mol/mol) |
CTRPv2 |
pan-cancer |
AAC |
0.15 |
2e-05 |
mRNA |
serdemetan:SCH-529074 (1:1 mol/mol) |
CTRPv2 |
pan-cancer |
AAC |
0.15 |
2e-05 |
mRNA |
navitoclax:MST-312 (1:1 mol/mol) |
CTRPv2 |
pan-cancer |
AAC |
0.15 |
3e-05 |
mRNA |
BRD-K02492147 |
CTRPv2 |
pan-cancer |
AAC |
0.16 |
7e-05 |